Nivo + ipi in unresectable stage III/IV melanoma
Michael Postow, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, USA, talks through data from a phase II…
Related Articles
Colonoscopy: primary screening with evolving challenges
Aasma Shauka, MD, MPH, New York University, New York, NY, discusses the current landscape of colonoscopy screening in the United States. Colonoscopy is the primary…
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, summarizes the emerging immunotherapeutic treatment landscape for patients with melanoma. The ongoing Phase III INTerpath-001 trial…
Assessing operability in NSCLC: challenges and considerations
Mariana Brandao, MD, PhD, Institute Jules Bordet, Brussels, Belgium, delves into the complexities of defining operability in non-small cell lung cancer (NSCLC), acknowledging the unique…
Lung cancer initiation: towards molecular cancer prevention
Charles Swanton, Francis Crick Institute in London, discusses his research on the initiation and progression of lung cancer in response to air pollution exposure. Focusing…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
CHRYSALIS: amivantamab in wild-type, pre-treated NSCLC
Natasha Leighl, MD, University of Toronto, Toronto, Canada, discusses findings from the Phase Ib CHRYSALIS trial (NCT02609776) of amivantamab, an EGFR-MET bispecific antibody, in patients…
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata, PhD, University of Tokyo, Tokyo, Japan, comments on emerging biomolecular therapeutic targets for the treatment of patients with gastric and gastroesophageal cancers. Promising…
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat, from The Royal Marsden NHS Foundation Trust in London, UK, shares his enthusiasm for the BTOG 2024 congress in Belfast, UK, which gathered…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…